InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by 임한일, Vice-Président. Director active across 2 companies, notably 대원제약. In total, 4 reports have been published. Activity tracked since 11 March 2026. The latest transaction was filed on 11 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
4 of 4 declarations
Lim Han-il is the vice president at Daewon Pharmaceutical, a South Korean company specializing in the pharmaceutical industry. In his role, he oversees operations and contributes to the company's strategy, aiming to improve efficiency and profitability. His experience is valuable in guiding Daewon Pharmaceutical to new heights.